long term glp 1 use effects of Clinical Recommendations to Manage Gastrointestinal Adverse Events in Patients The unknown trajectory of GLP-1

Both patterns are normal and typically resolve within 2 to 4 weeks

And patients want to access these medications at an affordable price point. Many insurers are narrowing eligibility for GLP-1 coverage to high-risk patientstypically those with Type 2 diabetes, or with a BMI over a certain threshold and a weight-related comorbidity (e.g., hypertension, sleep apnea)

Additionally, the study did not account for the type of GLP-1 medication or length of use, genetic risk factors, or cancer stage or type at diagnosis

government announced in January it has included GLP-1 drugs in Medicares price negotiation program, aiming to reduce costs for beneficiaries starting in 2027

After screening for biliary disorder AEs, 1,709 reports were identified for GLP-1 RAs and 506 for DPP-4 inhibitors (Table 2)